<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>4331004 Figure_1-A</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>Heat map showing two distinct types of AR binding locations. Agonist (DHT) induced AR binding in 34,442 agonist&#8208;responsive regions. Antagonist (bicalutamide and enzalutamide)&#8208;enhanced AR recruitment in 3,292 antagonist&#8208;responsive loci. The normalized average signal density of reads 2 is also shown for each condition.</text>
      <annotation id="1">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">4</infon>
        <location offset="39" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">5</infon>
        <location offset="70" length="3"/>
        <text>DHT</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:3090</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">6</infon>
        <location offset="146" length="12"/>
        <text>bicalutamide</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CHEBI:68534</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">7</infon>
        <location offset="163" length="12"/>
        <text>enzalutamide</text>
      </annotation>
      <annotation id="5">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">8</infon>
        <location offset="83" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="6">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">9</infon>
        <location offset="188" length="2"/>
        <text>AR</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_2-A</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A ARChIP&#8208;exo defines four types of high&#8208;confidence agonist&#8208;liganded ARBEs. Numbers indicate motif counts. The first two columns of each ARBE panel show normalized tags distribution over ARBEs on the forward (blue) and reverse (red) strands, separately. Forward strand refers to the motif&#8208;containing strand. The aggregated tag density is shown at the top of the raw signal plots. The third column of each ARBE panel represents the bound motif sequences ordered as in the left two columns.</text>
      <annotation id="1">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">14</infon>
        <location offset="2" length="2"/>
        <text>AR</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_3-B</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B ARBE reporter constructs were transiently transfected into LNCaP cells. Cells were stimulated with DHT (100 nM), a synthetic androgen R1881 (10 nM), or vehicle for 16-24 h, and luciferase activities were measured. The results were presented as the mean &#177; SD of the quadruplicate transfections. The genomic positions of ARBEs are also shown.</text>
      <annotation id="1">
        <infon key="type">CVCL_0395</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">17</infon>
        <location offset="61" length="5"/>
        <text>LNCaP</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CHEBI:379896</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">18</infon>
        <location offset="136" length="5"/>
        <text>R1881</text>
      </annotation>
      <annotation id="3">
        <infon key="type">gene:luciferase</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">19</infon>
        <location offset="179" length="10"/>
        <text>luciferase</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">20</infon>
        <location offset="101" length="3"/>
        <text>DHT</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_3-C</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C UCSC genome browser showing signals on ChIP&#8208;exo defined TMPRSS2 &#8722;13.5 kb enhancer ARBE.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:7113</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">31</infon>
        <location offset="60" length="7"/>
        <text>TMPRSS2</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_3-D</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Enhancer activity was compared between literature&#8208;based ARE and Exo&#8208;defined ARBE in TMPRSS2 locus by reporter gene assay.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:7113</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">35</infon>
        <location offset="90" length="7"/>
        <text>TMPRSS2</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_3-E</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E ARBE2 and ARBE4 were validated in TMPRSS2 enhancer through WT or Mut construct transfections. The results were presented as the mean &#177; SD of the quadruplicate transfections.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:7113</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">42</infon>
        <location offset="36" length="7"/>
        <text>TMPRSS2</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_3-F</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Two ARBE1 regions were changed to ARBE2, ARBE3, or ARBE4 through mutations at nucleotide 5 and/or 6. Cells were stimulated with DHT (100 nM), R1881 (10 nM), or vehicle for 16-24 h, and luciferase activities were measured. The results were presented as the mean &#177; SD of the quadruplicate transfections. The genomic positions of ARBEs are also shown.</text>
      <annotation id="1">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">53</infon>
        <location offset="130" length="3"/>
        <text>DHT</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CHEBI:379896</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">54</infon>
        <location offset="144" length="5"/>
        <text>R1881</text>
      </annotation>
      <annotation id="3">
        <infon key="type">gene:luciferase</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">55</infon>
        <location offset="187" length="10"/>
        <text>luciferase</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_4-A</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Aggregated sequencing tag distribution of ARChIP&#8208;exo and H3K4me2 MNaseChIP&#8208;seq around the four precisely defined ARBEs. ChIP&#8208;exo density plot is shown as forward (blue) and reverse (red) strands, respectively. H3K4me2 signal is shown in green. The window indicates &#177; 500 bp regions from the ARBE motif (0).</text>
      <annotation id="1">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">61</infon>
        <location offset="44" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="2">
        <infon key="type">protein:H3</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">63</infon>
        <location offset="61" length="2"/>
        <text>H3</text>
      </annotation>
      <annotation id="3">
        <infon key="type">protein:MNase</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">64</infon>
        <location offset="69" length="5"/>
        <text>MNase</text>
      </annotation>
      <annotation id="4">
        <infon key="type">protein:H3</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">66</infon>
        <location offset="218" length="2"/>
        <text>H3</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_4-B</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Partitional clustering of the 4 types of ARBE locations based on dynamic signal shifting of H3K4me2 affected by DHT treatment.</text>
      <annotation id="1">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">70</infon>
        <location offset="114" length="3"/>
        <text>DHT</text>
      </annotation>
      <annotation id="2">
        <infon key="type">protein:H3</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">71</infon>
        <location offset="94" length="2"/>
        <text>H3</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_4-F</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F SNP frequency comparison between each type of ARBE and whole&#8208;genome control. **P  1E&#8208;8, *P  1E&#8208;5.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_5-A</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Heat map showing raw tags distribution over the four types of agonist&#8208;responsive ARBEs in LNCaP cells treated with vehicle, bicalutamide (10 &#956;M), bicalutamide plus DHT (10 nM), enzalutamide (10 &#956;M), or enzalutamide plus DHT (10 nM). The order of sequences in each type of ARBE is the same as the order of sequences shown in Fig A.</text>
      <annotation id="1">
        <infon key="type">CVCL_0395</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">84</infon>
        <location offset="94" length="5"/>
        <text>LNCaP</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CHEBI:3090</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">85</infon>
        <location offset="128" length="12"/>
        <text>bicalutamide</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:3090</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">86</infon>
        <location offset="151" length="12"/>
        <text>bicalutamide</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">87</infon>
        <location offset="169" length="3"/>
        <text>DHT</text>
      </annotation>
      <annotation id="5">
        <infon key="type">CHEBI:68534</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">88</infon>
        <location offset="182" length="12"/>
        <text>enzalutamide</text>
      </annotation>
      <annotation id="6">
        <infon key="type">CHEBI:68534</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">89</infon>
        <location offset="208" length="12"/>
        <text>enzalutamide</text>
      </annotation>
      <annotation id="7">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">90</infon>
        <location offset="226" length="3"/>
        <text>DHT</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_5-B</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B UCSC genome browser views of sequencing data at KLK3 locus under different conditions.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:354</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">94</infon>
        <location offset="50" length="4"/>
        <text>KLK3</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_5-C</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Regular ChIP analysis of AR on KLK3 enhancer. LNCaP cells were treated with or without agonist and antagonist for 4 h. The data are presented as the fold enrichment over IgG (mean &#177; SD, n = 3).</text>
      <annotation id="1">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">102</infon>
        <location offset="27" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:354</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">103</infon>
        <location offset="33" length="4"/>
        <text>KLK3</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CVCL_0395</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">104</infon>
        <location offset="48" length="5"/>
        <text>LNCaP</text>
      </annotation>
      <annotation id="4">
        <infon key="type">GO:0071735</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">105</infon>
        <location offset="172" length="3"/>
        <text>IgG</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_5-D</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Quantitative RT&#8208;PCR was performed to assess KLK3 mRNA levels under agonist or antagonist treatments. The data are the mean of triplicates &#177; SD.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:354</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">112</infon>
        <location offset="48" length="4"/>
        <text>KLK3</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_5-E</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Eight agonist&#8208;responsive ARBE reporter constructs used in Fig B were transiently transfected into LNCaP cells. Cells were stimulated with vehicle, DHT (100 nM), bicalutamide (10 &#956;M), bicalutamide plus DHT, enzalutamide (10 &#956;M), or enzalutamide plus DHT for 16-24 h, and luciferase activities were measured. The results are presented as the mean &#177; SD of the quadruplicate transfections.</text>
      <annotation id="1">
        <infon key="type">CVCL_0395</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">117</infon>
        <location offset="102" length="5"/>
        <text>LNCaP</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">118</infon>
        <location offset="151" length="3"/>
        <text>DHT</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:3090</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">119</infon>
        <location offset="165" length="12"/>
        <text>bicalutamide</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CHEBI:3090</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">120</infon>
        <location offset="188" length="12"/>
        <text>bicalutamide</text>
      </annotation>
      <annotation id="5">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">121</infon>
        <location offset="206" length="3"/>
        <text>DHT</text>
      </annotation>
      <annotation id="6">
        <infon key="type">CHEBI:68534</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">122</infon>
        <location offset="211" length="12"/>
        <text>enzalutamide</text>
      </annotation>
      <annotation id="7">
        <infon key="type">CHEBI:68534</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">123</infon>
        <location offset="237" length="12"/>
        <text>enzalutamide</text>
      </annotation>
      <annotation id="8">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">124</infon>
        <location offset="255" length="3"/>
        <text>DHT</text>
      </annotation>
      <annotation id="9">
        <infon key="type">gene:luciferase</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">125</infon>
        <location offset="276" length="10"/>
        <text>luciferase</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-A</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Heat map showing the signal intensity of AR binding in LNCaP cells treated with DHT, bicalutamide, and enzalutamide, respectively. Numbers indicate the antagonist&#8208;responsive AR locations in each category.</text>
      <annotation id="1">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">129</infon>
        <location offset="43" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CVCL_0395</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">130</infon>
        <location offset="57" length="5"/>
        <text>LNCaP</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">131</infon>
        <location offset="82" length="3"/>
        <text>DHT</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CHEBI:3090</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">132</infon>
        <location offset="87" length="12"/>
        <text>bicalutamide</text>
      </annotation>
      <annotation id="5">
        <infon key="type">CHEBI:68534</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">133</infon>
        <location offset="105" length="12"/>
        <text>enzalutamide</text>
      </annotation>
      <annotation id="6">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">134</infon>
        <location offset="178" length="2"/>
        <text>AR</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-B</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Clustering of the antagonist&#8208;responsive AR locations based on dynamic signal shifting of H3K4me2 affected by DHT treatment.</text>
      <annotation id="1">
        <infon key="type">protein:H3</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">137</infon>
        <location offset="93" length="2"/>
        <text>H3</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">138</infon>
        <location offset="44" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">139</infon>
        <location offset="113" length="3"/>
        <text>DHT</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-C</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C The aggregated tag density is shown on the forward (blue) and reverse (red) strands, separately. The bottom panel represents the bound motif sequences found in the antagonist&#8208;responsive AR locations. Antagonist&#8208;liganded ARBE is also shown.</text>
      <annotation id="1">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">143</infon>
        <location offset="190" length="2"/>
        <text>AR</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-D</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D EMSA was performed to validate specific AR binding to antagonist&#8208;liganded ARBEs. Biotin&#8208;labeled wild&#8208;type (WT) or mutated (Mut) probes were incubated with same amounts of nuclear extract from LNCaP cells treated with bicalutamide or enzalutamide. Arrow indicates the position of the shifted specific probe. Four probes (M1-M4) were randomly selected. Quantification of EMSA gel bands shows that antagonists increase the in vitro binding to 1.7-3.8&#8208;fold compared to the vehicle.</text>
      <annotation id="1">
        <infon key="type">molecule:Biotin</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">150</infon>
        <location offset="85" length="6"/>
        <text>Biotin</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">151</infon>
        <location offset="42" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CVCL_0395</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">153</infon>
        <location offset="200" length="5"/>
        <text>LNCaP</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CHEBI:3090</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">154</infon>
        <location offset="225" length="12"/>
        <text>bicalutamide</text>
      </annotation>
      <annotation id="5">
        <infon key="type">CHEBI:68534</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">155</infon>
        <location offset="241" length="12"/>
        <text>enzalutamide</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-E</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Top panel represents overlap between genes within 20 kb of the bicalutamide&#8208;responsive AR locations and enzalutamide&#8208;responsive AR locations. Bottom panel indicates microarray analysis of genes around enzalutamide&#8208;responsive AR locations following treatment with DHT or enzalutamide in LNCaP cells.</text>
      <annotation id="1">
        <infon key="type">CHEBI:3090</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">159</infon>
        <location offset="65" length="12"/>
        <text>bicalutamide</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">160</infon>
        <location offset="91" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:68534</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">161</infon>
        <location offset="108" length="12"/>
        <text>enzalutamide</text>
      </annotation>
      <annotation id="4">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">162</infon>
        <location offset="134" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="5">
        <infon key="type">CHEBI:68534</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">163</infon>
        <location offset="207" length="12"/>
        <text>enzalutamide</text>
      </annotation>
      <annotation id="6">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">164</infon>
        <location offset="233" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="7">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">165</infon>
        <location offset="271" length="3"/>
        <text>DHT</text>
      </annotation>
      <annotation id="8">
        <infon key="type">CHEBI:68534</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">166</infon>
        <location offset="278" length="12"/>
        <text>enzalutamide</text>
      </annotation>
      <annotation id="9">
        <infon key="type">CVCL_0395</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">167</infon>
        <location offset="294" length="5"/>
        <text>LNCaP</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-F</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>F UCSC genome browser views of sequencing data at CPEB4 locus under different conditions. The blue region represents antagonist&#8208;responsive AR location, while the two pink regions indicate agonist&#8208;responsive AR locations.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:80315</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">171</infon>
        <location offset="50" length="5"/>
        <text>CPEB4</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">172</infon>
        <location offset="141" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">173</infon>
        <location offset="211" length="2"/>
        <text>AR</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-G</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G</infon>
    <passage>
      <offset>0</offset>
      <text>G ARChIP&#8208;exo library validation on antagonist&#8208;responsive and agonist&#8208;responsive AR locations referred to (F). The data are the mean of triplicates &#177; SD.</text>
      <annotation id="1">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">178</infon>
        <location offset="2" length="2"/>
        <text>AR</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-H</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-H</infon>
    <passage>
      <offset>0</offset>
      <text>H mRNA levels of CPEB4 were examined in cells treated with or without DHT and enzalutamide. The data are the mean of triplicates &#177; SD.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:80315</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">184</infon>
        <location offset="17" length="5"/>
        <text>CPEB4</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">185</infon>
        <location offset="70" length="3"/>
        <text>DHT</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:68534</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">186</infon>
        <location offset="78" length="12"/>
        <text>enzalutamide</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-I</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-I</infon>
    <infon key="sourcedata_figure_dir">Figure_6-I</infon>
    <passage>
      <offset>0</offset>
      <text>I Silencing of CPEB4 enhanced the inhibitory effects of enzalutamide in LNCaP cells. LNCaP cells were transfected with a control siRNA or siCPEB4. Cells were then treated with vehicle or 1 &#956;M enzalutamide, and cell numbers were determined on day 3 with a direct viable cell count assay. The data are the mean of triplicates &#177; SD.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:80315</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">188</infon>
        <location offset="140" length="5"/>
        <text>CPEB4</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:80315</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">189</infon>
        <location offset="15" length="5"/>
        <text>CPEB4</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:68534</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">190</infon>
        <location offset="56" length="12"/>
        <text>enzalutamide</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CVCL_0395</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">191</infon>
        <location offset="72" length="5"/>
        <text>LNCaP</text>
      </annotation>
      <annotation id="5">
        <infon key="type">CVCL_0395</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">192</infon>
        <location offset="85" length="5"/>
        <text>LNCaP</text>
      </annotation>
      <annotation id="6">
        <infon key="type">CHEBI:68534</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">193</infon>
        <location offset="193" length="12"/>
        <text>enzalutamide</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_7-A</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Immunohistochemistry (IHC) detection of AR in four malignant prostatetumors and two paired NATs. Representative microphotographs of HE staining showed normal prostatic gland (NATs) and poorly differentiated adenocarcinoma cells. IHC analysis indicated heterogeneous AR expression among patients. Magnification, 40&#215;. N1a and M3a were collected from the same patient ((Supplementary Table S5). N2b and M4b were gathered from another patient ((Supplementary Table S5).</text>
      <annotation id="1">
        <infon key="type">tissue:tumors</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">199</infon>
        <location offset="71" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uberon:UBERON:0002367</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">200</infon>
        <location offset="63" length="8"/>
        <text>prostate</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uberon:UBERON:0002367</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">203</infon>
        <location offset="160" length="15"/>
        <text>prostatic gland</text>
      </annotation>
      <annotation id="4">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">204</infon>
        <location offset="42" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="5">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">206</infon>
        <location offset="268" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="6">
        <infon key="type">NCBI taxon:9606</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">207</infon>
        <location offset="288" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_7-B</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Tissue ARChIP&#8208;exo raw signal intensity showing 1,715 enhanced AR binding locations in malignant prostatetumors (M) compared to NATs (N). ChIP&#8208;exo data of LNCaP (+DHT) is plotted around the same locations.</text>
      <annotation id="1">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">208</infon>
        <location offset="9" length="2"/>
        <text>AR</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uberon:UBERON:0002367</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">211</infon>
        <location offset="100" length="8"/>
        <text>prostate</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">212</infon>
        <location offset="108" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CVCL_0395</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">213</infon>
        <location offset="160" length="5"/>
        <text>LNCaP</text>
      </annotation>
      <annotation id="5">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">214</infon>
        <location offset="168" length="3"/>
        <text>DHT</text>
      </annotation>
      <annotation id="6">
        <infon key="type">Uniprot:P10275</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">216</infon>
        <location offset="66" length="2"/>
        <text>AR</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_7-D</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Oncomine analysis showing median rank for genes in the PROSTATIC NEOPLASMS network across 16 analyses of overexpression in prostate cancer (PCa) versus normal. The right column represents fold change in gene expression detected by RNA&#8208;seq in the LNCaP cell line after DHT treatment (Log2 FC DHT/Vehicle, P  0.01).</text>
      <annotation id="1">
        <infon key="type">Uberon:UBERON:0002367</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">218</infon>
        <location offset="125" length="8"/>
        <text>prostate</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CVCL_0395</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">219</infon>
        <location offset="250" length="5"/>
        <text>LNCaP</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">220</infon>
        <location offset="272" length="3"/>
        <text>DHT</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CHEBI:41876</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">221</infon>
        <location offset="295" length="3"/>
        <text>DHT</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_7-E</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Survival curves were generated based on Kaplan-Meier analysis. For each of the four clinical datasets, up to one&#8208;third of genes in the PROSTATIC NEOPLASMS network was selected based on gene expression level. These genes were then used to stratify patients. The P&#8208;values were calculated by log&#8208;rank test.</text>
      <annotation id="1">
        <infon key="type">NCBI taxon:9606</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">226</infon>
        <location offset="251" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
  </document>
</collection>
